Document is current
Any future updates will be listed below
-
Authors
Zhu, Zhaohua http://orcid.org/0000-0003-3913-2564
Yu, Qinghong
Leng, Xiaomei
Han, Weiyu
Li, Zhanguo
Huang, Cibo
Gu, Jieruo
Zhao, Yi
Wang, Kang
Li, Tianwang
Mei, Yifang
Xu, Jianhua
Zhang, Zhiyi
Hunter, David
Cicuttini, Flavia
Zeng, Xiaofeng
Ding, Changhai
-
Funding
Funding for this research was provided by:
Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education (LC2019ZD015)
- License Information
-
More Information
Article History
Received: 16 March 2020
Accepted: 14 August 2020
First Online: 16 September 2020
Ethics approval and consent to participate
: An ethics review has been provided by the Ethics Committee of Zhujiang Hospital (2018-FSMYK-001) to ensure compliance with national regulations for the protection of human medical research participants. Any significant modifications to the protocols that may impact the conduct of trial, treatment parameters, study aims, or study procedures will require a formal amendment to the protocol and approval by the Ethics Committee of Zhujiang Hospital. Informed written consent will be obtained from all participants by rheumatologists. On the consent form, participants will be asked if they agree to use their data and collect their blood samples. Participants will also be asked for permission to share relevant data within research teams from different hospitals. The clinical trial has been registered on ClinicalTrials.gov with a trial registration number NCT03815448. Any data required to support the protocol can be supplied on request from the corresponding author.
: Not applicable.
: The authors declare that they have no conflict of interests.
